// App-Quantinova.ai

4124 : Impact of second-line treatment (2L T) in advanced pancreatic cancer (APDAC) patients (pts) receiving first line Nab-Paclitaxel (nab-P) + Gemcitabine (G): an Italian multicentre real life experience.

Researchers

Presenter

  • Guido Giordano

Principal Investigators

  • Michele Milella

  • Vanja Vaccaro

  • Davide Melisi

  • Luisa Foltran

  • Vittorina Zagonel

  • Alberto Zaniboni

  • Paola Bertocchi

  • Francesca Bergamo

  • Alessandro Passardi

  • Gianna Musettini

  • Elisa Giommoni

  • Aldo Iop

  • Maria Bernardetta Aloi

  • Silvia Vecchiarelli

  • Enrico Vasile

  • Giovanni Lo Re

  • Mariacristina Di Marco

  • Ferdinando De Vita

Medical Centers

  • Oncologia Medica, Ospedale Sacro Cuore di Gesu' Fatebenefratelli, Benevento, Italy

  • Oncologia Medica, Ospedale Sacro Cuore di Gesu' Fatebenefratelli, Benevento, Italy

  • Regina Elena National Cancer Institute, Rome, Italy

  • Oncologia Medica, Istituto Nazionale Tumori Regina Elena, Roma, Italy

  • Digestive Molecular Clinical Oncology, University of Verona, Verona, Italy

  • Santa Maria degli Angeli GH, Pordenone, Italy

  • Medical Oncology 1, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy

  • Fondazione Poliambulanza, Brescia, Italy

  • Department of Medical Oncology, Fondazione Poliambulanza, Brescia, Italy

  • U.O. Oncologia Medica 2, Istituto Oncologico Veneto - IRCCS, Padova, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • U.O. Oncologia Medica II, Universitaria Ospedale S. Chiara, Azienda Ospedaliero-Universitaria Pisana Istituto Toscano Tumori, Pisa, Italy

  • SC Oncologia Medica, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy

  • Div of Medcl Oncology, Udine, UD, Italy

  • Medical Oncology, Ospedale Businco, Cagliari, Italy

  • Oncology Unit, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy, Bologna, Italy

  • U.O. Oncologia Medica II, Azienda Ospedaliero-Universitaria Pisana Istituto Toscano Tumori, Pisa, Italy

  • OSPEDALE S.M. DEGLI ANGELI, Pordenone, Italy

  • Department of Specialized, Experimental, and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy, Bologna, Italy

  • Medical Oncology, Second University of Naples, Naples, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved